Budesonide Inhalant
Product Images NDC 69097-319

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 69097-319). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

87894b75 A8c5 4d48 81bd 5ad43d66afc3 01

Chemical structure of Budesonide, the active ingredient in Budesonide Inhalation Suspension. The diagram shows the molecular arrangement including carbon, hydrogen, oxygen atoms, and functional groups typical of this corticosteroid compound.*

FDA Label Image

87894b75 A8c5 4d48 81bd 5ad43d66afc3 02

A line graph showing the mean change from baseline in nighttime asthma symptoms over a 12-week period for different doses of Budesonide Inhalation Suspension (0.25 mg, 0.5 mg, 1.0 mg once daily) compared to placebo. The x-axis represents time intervals from baseline to week 12, and the y-axis shows the mean change in symptom scores.*

FDA Label Image

87894b75 A8c5 4d48 81bd 5ad43d66afc3 03

A line graph showing mean change from baseline nighttime asthma symptoms over a 12-week period, with separate lines representing different dosing regimens of Budesonide Inhalation Suspension: 0.25 mg twice daily, 0.5 mg twice daily, and 1 mg twice daily, compared to placebo. The x-axis is labeled with time intervals (Baseline, Week >0-2, Week >2-4, Week >4-6, Week >6-8, Week >8-10, Week >10-12, Weeks 0-12) and the y-axis shows mean change values from -0.6 to 0.1.*

FDA Label Image

87894b75 A8c5 4d48 81bd 5ad43d66afc3 04

Line graph showing mean change from baseline in nighttime asthma symptoms over a 12-week period for Budesonide Inhalation Suspension at strengths 0.25 mg once daily, 0.25 mg twice daily, 0.5 mg twice daily, and 1.0 mg once daily, compared to placebo. Data points are plotted weekly in intervals, illustrating symptom change trends over time for each dosing group and placebo.*

FDA Label Image

87894b75 A8c5 4d48 81bd 5ad43d66afc3 05

An instructional illustration showing a hand holding a small vial with a flip-top cap being opened by lifting the top tab. The vial is positioned above a circular holder, with an arrow indicating a twisting motion to open or prepare the vial for use. This image relates to the handling or preparation of the Budesonide Inhalation Suspension inhalant.*

FDA Label Image

87894b75 A8c5 4d48 81bd 5ad43d66afc3 06

An instructional illustration showing two hands opening a small vial or ampule by snapping off the top at the scored neck. The image is a step labeled as step 3 in a sequence, likely demonstrating how to prepare Budesonide Inhalation Suspension for administration.*

FDA Label Image

87894b75 A8c5 4d48 81bd 5ad43d66afc3 07

An instructional illustration showing a person holding an inhalation device in one hand while using the other hand to insert or adjust the Budesonide Inhalation Suspension container into the device, demonstrating part of the preparation or assembly process.*

FDA Label Image

87894b75 A8c5 4d48 81bd 5ad43d66afc3 08

Label for Budesonide Inhalation Suspension 0.25 mg/2 mL oral inhalant by Cipla USA Inc. The label notes the product is a sterile suspension in single-dose 2 mL ampules. It includes storage instructions, directions to shake well before use, and cautions for use only once ampule is opened. The label features a lot number, barcode, and a white patch for authenticity.*

FDA Label Image

87894b75 A8c5 4d48 81bd 5ad43d66afc3 09

Packaging label for Budesonide Inhalation Suspension 0.25 mg/2 mL oral inhalant by Cipla USA Inc. The label indicates it is a human prescription drug, with dosing instructions to store upright and use single-dose ampules in foil pouches. The label includes directions, dosage strength, and manufacturer details.*

FDA Label Image

87894b75 A8c5 4d48 81bd 5ad43d66afc3 10

Label for Budesonide Inhalation Suspension 0.5 mg/2 mL single-dose ampule by Cipla USA Inc. The label indicates the product is a sterile inhalation suspension for oral use, with dosage and storage instructions, including temperature and handling guidelines. The label includes the NDC 69097-319-32 and manufacturer information.*

FDA Label Image

87894b75 A8c5 4d48 81bd 5ad43d66afc3 11

Packaging label for Budesonide Inhalation Suspension 0.5 mg/2 mL by Cipla USA Inc. The label indicates this is an oral inhalant prescription drug presented in 30 single-dose 2 mL ampules, each in a foil pouch. Directions include storage upright and usage for inhalation only. The label features drug name, strength, NDC number, and manufacturer details.*

FDA Label Image

87894b75 A8c5 4d48 81bd 5ad43d66afc3 12

Label for Budesonide Inhalation Suspension 1 mg/2 mL by Cipla USA Inc. The inhalant is intended for oral use, supplied in single-dose 2 mL ampules. The label includes dosage instructions, storage conditions at 20°C to 25°C, and cautions against using an ultrasonic nebulizer. The NDC is 69097-321-32, and the label notes that the product is Rx only.*

FDA Label Image

87894b75 A8c5 4d48 81bd 5ad43d66afc3 13

Packaging label for Budesonide Inhalation Suspension 1 mg/2 mL by Cipla USA Inc. The label indicates the product is for oral inhalation only, presented as 30 single-dose ampules of 2 mL each in foil pouches. It includes storage instructions to store upright and dispensation guidance.*

FDA Label Image

87894b75 A8c5 4d48 81bd 5ad43d66afc3 14

Label for Budesonide Inhalation Suspension 0.25 mg/2 mL by Cipla USA Inc. This prescription oral inhalant comes in single-dose ampules with five 2 mL ampules per envelope. The label includes dosage instructions, storage conditions, and manufacturer information. The product NDC is 69097-318-86.*

FDA Label Image

87894b75 A8c5 4d48 81bd 5ad43d66afc3 15

Packaging label for Budesonide Inhalation Suspension 0.25 mg/2 mL by Cipla USA Inc. The label shows the product name, strength, dosage form (inhalation suspension), and quantity of 30 single-dose ampules per carton. It includes instructions for use, storage directions, and barcodes. The label indicates "Rx Only" and features the Cipla logo.*

FDA Label Image

87894b75 A8c5 4d48 81bd 5ad43d66afc3 16

Budesonide Inhalation Suspension 0.5 mg/2 mL label for oral inhalant, containing 1 envelope with five 2 mL single-dose ampules. The label includes usage instructions and storage conditions. Produced by Cipla USA Inc., it specifies inhalation use only and provides handling information such as temperature storage and packaging details.*

FDA Label Image

87894b75 A8c5 4d48 81bd 5ad43d66afc3 17

Label for Budesonide Inhalation Suspension 0.5 mg/2 mL by Cipla USA Inc., displaying the product name, strength, and dosage form. The label indicates 30 single-dose ampules per carton for oral inhalation use, with instructions for use illustrated in four steps. It includes storage directions and manufacturer information, with a barcode and NDC 69097-319-87.*

FDA Label Image

87894b75 A8c5 4d48 81bd 5ad43d66afc3 18

Budesonide Inhalation Suspension 1 mg/2 mL label for oral inhalant use. The label indicates a single-dose ampule packaging containing five 2 mL ampules. It includes manufacturer details for Cipla USA Inc., prescribing and storage instructions, and a barcode. The label states Rx only and specifies use for inhalation only.*

FDA Label Image

87894b75 A8c5 4d48 81bd 5ad43d66afc3 19

Label for Budesonide Inhalation Suspension 1 mg/2 mL ampules by Cipla USA Inc. The package contains 30 single-dose ampules for oral inhalation, marked Rx Only. Instructions for use and storage guidance to keep upright are included, along with manufacturer information and a barcode.*

FDA Label Image

87894b75 A8c5 4d48 81bd 5ad43d66afc3 797 2

An instructional illustration depicting the removal of a plastic ampule from a foil pouch, showing a hand gripping the ampule by the top, as the first step in preparing the Budesonide Inhalation Suspension inhalant for use.*

FDA Label Image

87894b75 A8c5 4d48 81bd 5ad43d66afc3 797 3

An instructional illustration showing hands opening or separating a small plastic vial from a strip of four connected vials, likely representing single-dose units of an inhalation suspension product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.